04 Dec 2007 Arana Announces Phase II Trials For Lead Compound ART621
04 Dec 2007 Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement
04 Dec 2007 Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
04 Dec 2007 Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
03 Dec 2007 "Actemra(R)," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe
02 Dec 2007 Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration
29 Nov 2007 New Data Highlight That Treatment With Erbitux Allows More Resections of Preteated Patients With Metastatic Colorectal Cancer
29 Nov 2007 Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies
28 Nov 2007 MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer
26 Nov 2007 MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
21 Nov 2007 Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis
21 Nov 2007 Kyto Biopharma Inc. Confirms Definitive Isolation of the Human Vitamin B12 Receptor (TCblR)
20 Nov 2007 Genmab and Glaxosmithkline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
20 Nov 2007 Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease
19 Nov 2007 Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
19 Nov 2007 Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
16 Nov 2007 CHMP Adopts Negative Opinion on Appeal on European Application For natalizumab for the Treatment of Crohn's Disease
16 Nov 2007 Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer
16 Nov 2007 UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
16 Nov 2007 Abbott's HUMIRA(R) Receives Positive Opinion from EMEA for Treatment of Moderate to Severe Plaque Psoriasis
14 Nov 2007 ThromboGenics Begins Preclinical Development of Anti-VPAC Antibody for Thrombocytopenia
14 Nov 2007 New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
13 Nov 2007 New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
12 Nov 2007 Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma
09 Nov 2007 Biogen Idec's Baminercept, the First Lymphotoxin-beta Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up